Selective Modification of Streptozotocin at the C3 Position to Improve Its Bioactivity as Antibiotic and Reduce Its Cytotoxicity Towards Insulin-Producing Β Cells

Antibiotics - Switzerland
doi 10.3390/antibiotics9040182

Related search